© 2020 MJH Life Sciences and HCPLive. All rights reserved.
© 2020 MJH Life Sciences™ and HCPLive. All rights reserved.
October 28, 2020
In a study presented at ACG, investigators find the rate of confirmed HCV infections remained stable pre- and post-interventions.
Brooks Cash, MD, discusses the importance of bowel preparation and surveillance in patients with diabetes.
Anti-TNFs, vedolizumab, ustekinumab, thiopurines, and 5-ASA were all linked to a lower risk of myocardial infarctions.
A poster presented at ACG provides an updated analysis of clostridium difficile infection in the tofacitinib UC clinical program.
Sulindac and eflornithine could help delay the need for lower gastrointestinal surgery for FAP patients.
October 27, 2020
New data presented at ACG 2020 shows NER1006 bowel preparation to be safe and efficacious in patients with diabetes preparing for their colonoscopy.
Researchers test 3 different doses of mirikizumab in both biologic experienced and naïve Crohn’s disease patients.
An expert discusses a study assessing the effects of low compliance to eosinophilic esophagitis therapies among pediatric patients.
Ustekinumab resulted in a reduction of both stool frequency and rectal bleeding for ulcerative colitis patients.
New research shows patients with chronic liver disease admitted for influenza had an increased risk of disease severity but not a higher odds of mortality.